Alan Auerbach
Vorstandsvorsitzender bei PUMA BIOTECHNOLOGY, INC.
Vermögen: 26 Mio $ am 31.05.2024
Profil
Alan H.
Auerbach is the founder of Puma Biotechnology, Inc. (founded in 2010) where he currently holds the title of Chairman, President & Chief Executive Officer.
He was also the founder of Cougar Biotechnology, Inc. (founded in 2003) where he held the title of President, Chief Executive Officer & Director until 2009.
In addition to his founding positions, Mr. Auerbach has held former job positions.
He was the Chairman, President & Chief Executive Officer of Innovative Acquisitions Corp.
He also served as an Independent Director at Radius Health, Inc. from 2011 to 2017.
Prior to that, he was a Vice President & Senior Research Analyst at Diagnostic Products Corp.
in 2011, and at Wells Fargo Securities (Old) from 1998 to 2003.
He was also a Vice President & Research Analyst at Seidler Cos., Inc. from 1997 to 1998.
Mr. Auerbach's education history includes an undergraduate degree from Boston University and a graduate degree from the University of Southern California.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
PUMA BIOTECHNOLOGY, INC.
14,19% | 22.04.2024 | 6 843 745 ( 14,19% ) | 26 Mio $ | 31.05.2024 |
Aktive Positionen von Alan Auerbach
Unternehmen | Position | Beginn |
---|---|---|
PUMA BIOTECHNOLOGY, INC. | Vorstandsvorsitzender | 01.10.2011 |
Ehemalige bekannte Positionen von Alan Auerbach
Unternehmen | Position | Ende |
---|---|---|
RADIUS HEALTH, INC. | Direktor/Vorstandsmitglied | 29.12.2017 |
Innovative Acquisitions Corp.
Innovative Acquisitions Corp. Financial ConglomeratesFinance Innovative Acquisitions Corp. operates as a blank check company. It engages in organizational efforts and obtaining initial financing. The firm intends to acquire or merge with an existing company. The company was founded on April 27, 2007 and is headquartered in Cumberland, RI. | Vorsitzender | 09.12.2011 |
Cougar Biotechnology, Inc. /Old/
Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Cougar Biotechnology, Inc. is a private biotechnology company. It is engaged in the field of oncology. Cougar Biotechnology has the financial backing of a well-established venture capital group that has a long-term, successful track record in oncology drug development and biotechnology research. The company is located in Los Angeles, CA. | Gründer | 13.07.2009 |
Wells Fargo Securities (Old) | Analyst-Equity | 01.04.2003 |
Seidler Cos., Inc. | Corporate Officer/Principal | 01.05.1998 |
Ausbildung von Alan Auerbach
Boston University | Undergraduate Degree |
University of Southern California | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PUMA BIOTECHNOLOGY, INC. | Health Technology |
Private Unternehmen | 6 |
---|---|
Diagnostic Products Corp.
Diagnostic Products Corp. Medical SpecialtiesHealth Technology Diagnostic Products Corp. provides immunodiagnostic systems, which includes IMMULITE series of immunoassay systems, more than 75 immunoassays. It also designs and manufactures automated laboratory instrumentation and automation solutions. Diagnostic Products is located in Los Angeles, CA. | Health Technology |
Radius Health, Inc.
Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Cougar Biotechnology, Inc. /Old/
Cougar Biotechnology, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Cougar Biotechnology, Inc. is a private biotechnology company. It is engaged in the field of oncology. Cougar Biotechnology has the financial backing of a well-established venture capital group that has a long-term, successful track record in oncology drug development and biotechnology research. The company is located in Los Angeles, CA. | Health Technology |
Innovative Acquisitions Corp.
Innovative Acquisitions Corp. Financial ConglomeratesFinance Innovative Acquisitions Corp. operates as a blank check company. It engages in organizational efforts and obtaining initial financing. The firm intends to acquire or merge with an existing company. The company was founded on April 27, 2007 and is headquartered in Cumberland, RI. | Finance |
Wells Fargo Securities (Old) | Finance |
Seidler Cos., Inc. | Finance |